Edit |   |
---|---|
Antigenic Specificity | APP Abeta, Human (Aducanumab biosimilar) |
Clone | Aducanumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human APP Abeta Recombinant Antibody (Aducanumab). Aducanumab, sold under the brand name Aduhelm, is a medication used to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody. Aducanumab targets aggregated forms of Amyloid beta (A ) found in the brains of people with Alzheimer's disease to reduce its buildup. |
Immunogen | n/a |
Other Names | Anti-APP Abeta Recombinant Antibody, Research Grade Aducanumab, Anti-Human APP Abeta Recombinant Antibody(Aducanumab), BART, BIIB-037, Antibody Drug Analogues, Monoclonal Antibody, YR1321, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1384260-65-4 |
Catalog # | YR1321 |
Price | please inquire |
Order / More Info | APP Abeta, Human (Aducanumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |